Podcast-Thyroid
Learning Objectives
At the end of this course, participants should be able to:
- Recognize the Spectrum of Thyroid Disorders in Pediatrics
- Interpret Thyroid Function Tests and Their Clinical Relevance
- Distinguish Between Pathological and Transient Thyroid Abnormalities
- Understand Referral Guidelines for Pediatric Endocrinology
- Apply Clinical Judgment in Managing Thyroid Disorders
Intended Audience:
This online course is designed for pediatricians, family physicians, and pediatric endocrinologists.
Abstract:
Thyroid disorders in pediatric patients present with a wide spectrum of clinical manifestations, from congenital hypothyroidism in neonates to acquired thyroid dysfunction in older children. This discussion provides a comprehensive review of the different presentations of thyroid abnormalities, including hypo- and hyperthyroidism, subclinical cases, and special considerations in conditions such as Trisomy 21 and obesity. The conversation highlights the appropriate diagnostic approach, including when to order thyroid function tests and the significance of antibody testing. While treatment strategies are a topic of their own, this session emphasizes the clinical judgment required in deciding when to refer pediatric patients to an endocrinologist for further evaluation and management.
Assessment and Earning CME Credit:
This course in English is not CME-accredited. However, it provides valuable educational content that can enhance your knowledge and skills in the subject matter. To receive CME credit for this course in Armenia, you must take the course in Armenian and complete the post-course quiz. You have three chances to achieve a passing score of 70%. Once you pass the quiz, we will send your information to the Armenian Ministry of Health for credits.
Anna Ryabets-Lienhard, DO
Anna Ryabets-Lienhard, D.O. is the Medical Director of Metabolic Bone and Mineral Disorders Program at the Division of Endocrinology, Diabetes, and Metabolism, Children’s Hospital Los Angeles (CHLA), and an Assistant Professor of Clinical Pediatrics, Keck School of Medicine of the University of Southern California. She is a board-certified pediatric endocrinologist and an attending physician at CHLA. Dr. Ryabets-Lienhard completed her pediatric residency and pediatric endocrinology fellowship at CHLA. Her research and clinical focus are on primary and secondary pediatric osteoporosis, such as Osteogenesis Imperfecta and Glucocorticoid-Induced Osteoporosis, as well as rickets and mineral disorders. She is a site principal investigator on multiple clinical trials and a co-principal investigator on a multidisciplinary multisite study of metabolic and orthopedic outcomes of patients with congenital forms of rickets. Dr. Ryabets-Lienhardis on the Board of Directors for the Human Growth Foundation and co-chair of the Drugs and Therapeutics Committee of the Pediatric Endocrine Society, USA.
